i-Base home
Search Menu
  • Home
  • HTB
  • PK Workshop 12th 2011

HTB

PK Workshop 12th 2011

12th International Workshop on Clinical Pharmacology of HIV Therapy, 13–-15 April 2011, Miami

1 May 2011. Related: Conference reports.

Quad reduces levels of oral contraceptives

1 May 2011. Related: Conference reports, Antiretrovirals, PK and drug interactions.

Elvitegravir/cobicistat and acid reducing agents

1 May 2011. Related: Conference reports, Antiretrovirals, PK and drug interactions.

Lopinavir/r reduces levels of rifabutin

1 May 2011. Related: Conference reports, Antiretrovirals, PK and drug interactions.

Cobicistat has little impact on CYP2D6 and CYP2B6

1 May 2011. Related: Conference reports, Antiretrovirals.

Atazanavir levels indicate need for higher dose during pregnancy

1 May 2011. Related: Conference reports, Antiretrovirals, Pregnancy.

Etravirine lowers levels of maraviroc given at 300 or 600 mg twice daily

1 May 2011. Related: Conference reports, Antiretrovirals.

Once-daily 150-mg maraviroc explored in people taking atazanavir/ritonavir

1 May 2011. Related: Conference reports, Antiretrovirals.

Lopinavir troughs lower in children on once-daily dose with efavirenz

1 May 2011. Related: Conference reports, Antiretrovirals, Paediatric care.

Dose optimisation: 50 mg ritonavir-boosting, 3TC dosing and raltegravir once-daily

1 May 2011. Related: Conference reports, Antiretrovirals, Treatment strategies.

  • HTB RSS

Early access

  • Cases of mpox reinfection in HIV negative men on PrEP: atovaquone, mefloquine and molnupiravir as potential treatments 15 March 2023
  • All early access reports

Current issues

  • March 2023
  • February 2023
  • December 2022
  • Back issues

Special report

  • Latest statistics on HIV in the UK: data for 2021 1 December 2022

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Advocate
Professional
Donate
Feedback
Advice and information
Q and A
Phoneline
Pocket info
Guides
HIV meds
Glossary
Research and conference reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
News and updates
News
Blogs
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
Sitemap
Home
Find us on Facebook
i-Base on Facebook